Health

  • April 27, 2026

    Convicted Pa. Dentist Says Feds Failed To Prove Fraud

    A Pennsylvania dentist convicted along with his brother for using their dental practice to defraud Medicare, install unapproved dental implants in patients, and falsify visas to recruit foreign workers has asked a federal judge for acquittal or a new trial, arguing the government failed to show he committed any crimes.

  • April 27, 2026

    Medical Group Says Secret Call Could Upend Estate's Verdict

    A Connecticut anesthesiology group has asked a state appeals court to reverse its portion of a $20 million wrongful death verdict, saying a lower court judge should have allowed into evidence a secret phone recording of a surgeon, used different verdict forms and blocked testimony from an allegedly unqualified witness.

  • April 27, 2026

    What To Watch As Justices Take On 'Skinny Label' Case

    The U.S. Supreme Court will hear arguments Wednesday on whether to permit a patent suit over a generic heart drug using a so-called skinny label, a case with ramifications for the drug industry that could shape patent disputes more broadly and other legal areas. Here's what to watch for.

  • April 27, 2026

    4th Circ. Says Medicaid Fraud Convictions Lacked Evidence

    The government failed to prove the former owner of a mental health counseling company in Virginia willfully committed fraud by falsely billing Medicaid $200,000 for counseling services on two specific dates, a panel of the Fourth Circuit has found, overturning his convictions.

  • April 27, 2026

    Ropes & Gray, Cooley Lead Lilly's $2.3B Cancer Drug Buy

    Eli Lilly and Co. said Monday it will acquire privately held Ajax Therapeutics in a deal worth up to $2.3 billion, as the drugmaker looks to expand its pipeline of treatments for blood cancers.

  • April 27, 2026

    US, Indian Firms Guide $11.75B Sun Pharma-Organon Deal

    Indian pharmaceutical giant Sun Pharmaceutical Industries Ltd. has agreed to acquire New Jersey-based Organon & Co. in an all-cash deal valued at $11.75 billion, with each side of the transaction having representation from one U.S. and one Indian law firm.

  • April 24, 2026

    Disability Groups Back Psilocybin Home Access In Ore.

    The Oregon Health Authority's refusal to allow home-based psilocybin services for terminally ill patients who cannot travel violates federal law, a coalition of disability rights groups have told an Oregon federal court in a brief in favor of broadening the state's psilocybin access program.

  • April 24, 2026

    Tenn. Abortion Ban Trial Taken Off Calendar Following Appeal

    A Tennessee state court has canceled a trial scheduled to begin Monday over a suit challenging the state's abortion ban and seeking clarification on when a physician can legally terminate a high-risk pregnancy.

  • April 24, 2026

    Ex-Medical Co. Employee Sues For Whistleblower Retaliation

    Luminis Health Inc. has been sued by a former employee alleging the Maryland-based healthcare group fired him for blowing the whistle on billing fraud and discriminated against him because of his race.

  • April 24, 2026

    Up Last At High Court: TPS, Geofence, Skinny Labels

    The U.S. Supreme Court will close out its oral argument portion of the 2025 October term by hearing a panoply of disputes over the constitutionality of geofence warrants, the existence of aiding and abetting torture claims, and the rescission of temporary protected status for hundreds of thousands of immigrants.

  • April 24, 2026

    Texas Justices Toss Trans Youth Probe Suit As Moot

    Texas officials were freed from court orders blocking them from launching probes on parents thought to have provided certain gender-affirming care to their children, with the state high court on Friday calling the underlying litigation moot after the state closed the investigations and the teenagers became adults.

  • April 24, 2026

    Natera Tells Justices CareDx Made Up Circ. Split In Petition

    Natera asked the U.S. Supreme Court to reject a petition from rival CareDx asking it to review a Third Circuit decision that erased a $45 million jury verdict stemming from CareDx's false advertising claims, saying Friday the circuit split that CareDx claims exists is "imagined."

  • April 24, 2026

    Atty In 'Maya' Case Isn't Owed $10M In Fees, Judge Told

    An attorney for Maya Kowalski, the subject of the Netflix documentary "Take Care of Maya," told a Florida judge Friday that her former lawyer has no right to $9.9 million in attorney fees because the fee agreement between them is unenforceable.

  • April 24, 2026

    Texas Panel Vacates $350K Unwanted Pregnancy Verdict

    A Texas appeals court has vacated a $350,000 verdict in favor of a woman suing her OB-GYN for failing to sterilize her, saying precedent from the state's supreme court holds that noneconomic damages from an unwanted pregnancy are unavailable, regardless of how that pregnancy ends.

  • April 24, 2026

    Cigna Plan Members Say HIPAA Notice Backs Privacy Claims

    A group of Cigna health plan participants who claimed the company failed to protect their private health information when it tracked their website activities told a Pennsylvania federal judge that the insurance giant should not be allowed to dodge new allegations that their HIPAA rights were violated.

  • April 24, 2026

    Blue Cross Licensee Seeks Exit From Claims Practices Suit

    A Blue Cross licensee told a Colorado federal judge that it has "no control" over Anthem Blue Cross and Blue Shield's provider network and therefore shouldn't have to face a treatment facilities operator's suit alleging it violated federal benefits and mental health parity laws.

  • April 24, 2026

    2 Plead Guilty Over Harvard Medical School Explosion

    Two Massachusetts men pled guilty Friday in Boston federal court to charges that they set off a commercial-grade firework inside a Harvard Medical School lab after a night of Halloween party-hopping last fall.

  • April 24, 2026

    Trump Admin Seeks Stay Of Vax Policy Suit Pending Appeal

    The Trump administration has asked a Massachusetts federal judge to press pause on a challenge to its new childhood vaccine schedule while it considers appealing the court's order blocking the changes, a request the plaintiffs called a delay tactic.

  • April 24, 2026

    Merck's $6.7B Terns Deal Clears Regulatory Hurdle

    Merck has cleared a key regulatory hurdle in its plan to acquire clinical stage oncology company Terns Pharmaceuticals Inc. for $6.7 billion, the pharmaceutical giant said Friday. 

  • April 24, 2026

    11th Circ. Panel Looks Split On Ga.'s Trans Prison Care Ban

    An Eleventh Circuit panel appeared divided Friday over whether to reverse a Georgia federal judge's order blocking the state from cutting off funding for transgender prisoners' hormone therapy, with one judge insisting that the state had de facto conceded the treatment was medically necessary.

  • April 24, 2026

    Taxation With Representation: Gibson Dunn, Paul Weiss

    In this week's Taxation With Representation, Elon Musk's SpaceX strikes a deal with Cursor that could lead to an acquisition of the artificial intelligence startup, building products distributor QXO Inc. buys TopBuild Corp., and Eli Lilly & Co. acquires clinical-stage biotechnology company Kelonia Therapeutics.

  • April 24, 2026

    2nd Circ. Nixes Cigna Retirees' Bid For Added Discovery

    The Second Circuit refused to restart proceedings in a class action from Cigna retirees who challenged changes to their pensions, ruling Friday that a lower court was correct to hold that the ex-workers hadn't shown the insurer was disregarding orders to reform their retirement plan. 

  • April 23, 2026

    Mass. Appeals Court Backs Hospital In Malpractice Suit

    The Massachusetts Appeals Court has affirmed the dismissal of a malpractice suit against Massachusetts General Hospital and three doctors, ruling that a patient who said he was not warned about the risk of fainting needed expert testimony to prove his claims.

  • April 23, 2026

    Fake Patients Got Braces Approved In Medicare Scheme

    An investigator with the U.S. Department of Health and Human Services told jurors on Thursday that a telemedicine doctor signed off on unnecessary orthotic braces for two fake personas he created to test out a software system that the government claims bilked Medicare out of nearly half a billion dollars.

  • April 23, 2026

    FTC Cuts Deal To End Anesthesia Group Rollup Case

    The Federal Trade Commission reached an agreement Thursday to settle its case accusing U.S. Anesthesia Partners Inc. of monopolizing the Texas anesthesia services market by purchasing most of the competing anesthesia practices in the state.

Expert Analysis

  • How State FCA Activity May Affect Civil Fraud Enforcement

    Author Photo

    A growing trend of state attorneys general enforcing their False Claims Act analogues independently of the U.S. Department of Justice carries potential repercussions for civil fraud enforcement and qui tam litigation considerations, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwen Stamper at Vogel Slade.

  • Wage-Based H-1B Rule Amplifies Lottery Risks For Law Firms

    Author Photo

    Under the wage-based H-1B lottery rule taking effect Feb. 27, law firms planning to hire noncitizen law graduates awaiting bar admission should consider their options, as the work performed by such candidates may sit at the intersection of multiple occupational classifications with differing chances of success, says Jun Li at Reid & Wise.

  • Series

    Judges On AI: Practical Use Cases In Chambers

    Author Photo

    U.S. Magistrate Judge Allison Goddard in the Southern District of California discusses how she uses generative artificial intelligence tools in chambers to make work more efficient and effective — from editing jury instructions for clarity to summarizing key documents.

  • Assessing Compliance Risks Around TrumpRx Participation

    Author Photo

    As there are novel compliance obligations and potential political opposition related to the new TrumpRx online drug platform, companies intending to participate on the site should consider the pressure points that are likely to draw enforcement scrutiny, say attorneys at Sheppard.

  • California's New Privacy Laws Demand Preparation From Cos.

    Author Photo

    An increase in breach disclosures is coinciding with California's most comprehensive privacy and artificial intelligence legislation taking effect, illustrating the range of vulnerabilities organizations in the state face and highlighting that the key to successfully managing these requirements is investing in capabilities before they became urgent, says Camilo Artiga-Purcell at Kiteworks.

  • Series

    Trail Running Makes Me A Better Lawyer

    Author Photo

    Navigating the muddy, root-filled path of trail marathons and ultramarathons provides fertile training ground for my high-stakes fractional general counsel work, teaching me to slow down my mind when the terrain shifts, sharpen my focus and trust my training, says Eric Proos at Next Era Legal.

  • Predicting Actual Impact From CDC's New Vaccine Guidance

    Author Photo

    Recent federal changes to the childhood immunization schedule, reducing the number of vaccine recommendations from 18 to 11, do not automatically create enforceable obligations for parents, schools or healthcare providers, but may spur litigation and other downstream effects on school policies and state guidelines, says Mehdi Sinaki at Michelman & Robinson.

  • AI Scientific Discovery Order Implications For Life Sciences

    Author Photo

    President Donald Trump's November executive order establishing a government effort to use artificial intelligence to accelerate scientific discovery has the potential to leverage significant federal resources and data to support research, drug and device approvals, and AI model training in the life sciences sector, say attorneys at Hogan Lovells.

  • What Rescheduling Means For Cannabis Labels, Marketing

    Author Photo

    The proposed reclassification of cannabis is expected to bring heightened scrutiny of labeling, advertising and marketing from the U.S. Food and Drug Administration and the Federal Trade Commission, but the brands that tighten evidence, standardize operations and professionalize marketing controls now will see fewer surprises and better outcomes, say attorneys at Wilson Elser.

  • What's At Stake In Possible Circuit Split On Medicaid Rule

    Author Photo

    A recent Eleventh Circuit decision, reviving Florida's lawsuit against a federal rule that reduces Medicaid funding based on agreements between hospitals, sets up a potential circuit split with the Fifth Circuit, with important ramifications for states looking to private administrators to run provider tax programs, say Liz Goodman, Karuna Seshasai and Rebecca Pitt at FTI Consulting.

  • Malpractice Claim Assignability Continues To Divide Courts

    Author Photo

    Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.

  • Courts' Rare Quash Of DOJ Subpoenas Has Lessons For Cos.

    Author Photo

    In a rare move, three federal courts recently quashed or partially quashed expansive U.S. Department of Justice administrative subpoenas issued to providers of gender-affirming care, demonstrating that courts will scrutinize purpose, cabin statutory authority and acknowledge the profound privacy burdens of overbroad government demands for sensitive records, say attorneys at ArentFox Schiff.

  • Unpacking Dormant Commerce Clause Cannabis Circuit Split

    Author Photo

    Federal courts have reached differing conclusions as to whether state-legal cannabis is subject to the dormant commerce clause, with four opinions across three circuit courts in the last year demonstrating the continued salience of the dormant commerce clause debate to the nation's cannabis industry, regulators and policymakers, say attorneys at Perkins Coie.

  • Remote Patient Monitoring Is At Regulatory Inflection Point

    Author Photo

    With remote patient monitoring at the center of new federal pilot programs and a recent report from the U.S. Department of Health and Human Services' Office of Inspector General examining Medicare billing for those services, it is clear that balancing innovation and risk will be a central challenge ahead for digital health stakeholders, say attorneys at Morgan Lewis.

  • Texas AG Wields Consumer Protection Law Against Tech Cos.

    Author Photo

    Texas Attorney General Ken Paxton has targeted technology companies using the Texas Deceptive Trade Practices Act, a broadly worded statute that gives the attorney general wide latitude to pursue claims beyond traditional consumer protection, creating unique litigation risks, say attorneys at Yetter Coleman.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.